Genetic variants of X-linked Alport syndrome in children: a single-center cohort study
Authors: Aksyonova M.E. ,   Research and Clinical Institute of Pediatrics and Pediatric Surgery named after Academician Yuri Veltischev with the Pirogov Russian National Research Medical University, Moscow, Russia, Konkova N.E. , Piruzeyeva O.R. , Zaykova N.M. , Lepayeva T.V. , Nikishina T.A. , Obukhova V.A. , Prikhodina L.S. ,   Research and Clinical Institute of Pediatrics and Pediatric Surgery named after Academician Yuri Veltischev with the Pirogov Russian National Research Medical University, Moscow, Russia,   Research and Clinical Institute of Pediatrics and Pediatric Surgery named after Academician Yuri Veltischev with the Pirogov Russian National Research Medical University, Moscow, Russia,   Research and Clinical Institute of Pediatrics and Pediatric Surgery named after Academician Yuri Veltischev with the Pirogov Russian National Research Medical University, Moscow, Russia,   Research and Clinical Institute of Pediatrics and Pediatric Surgery named after Academician Yuri Veltischev with the Pirogov Russian National Research Medical University, Moscow, Russia,   Research and Clinical Institute of Pediatrics and Pediatric Surgery named after Academician Yuri Veltischev with the Pirogov Russian National Research Medical University, Moscow, Russia,   Research and Clinical Institute of Pediatrics and Pediatric Surgery named after Academician Yuri Veltischev with the Pirogov Russian National Research Medical University, Moscow, Russia,   Research and Clinical Institute of Pediatrics and Pediatric Surgery named after Academician Yuri Veltischev with the Pirogov Russian National Research Medical University, Moscow, Russia
Published: August 2024

X-linked Alport syndrome (XLAS) is a monogenic disease characterized by the progressive nephropathy development, sensorineural hearing loss and the lens and retina pathology. The clinical manifestations of the syndrome and the renal prognosis of patients are determined by the nature of the gene COL4A5 mutation. The range of COL4A5 genetic variants is different among populations. Information about the XLAS genetic structure in Russian pediatric cohort is insufficient. The purpose of this research was to determine the features of the spectrum of the gene COL4A5 genetic variants in children with XLAS. Materials and methods used: a single-center retrospective cohort study included children aged 2 to 17 y/o with genetically confirmed XLAS. Descriptions of variants in gene COL4A5 were performed using genome build GRCh37/hg19 in accordance with the reference sequence GRCh37/hg19 (Reference Sequence, HGVS) and the American College of Medical Genetics and Genomics (ACMG), AMP Clinical Practice Guidelines. Results: analysis of data from 174 probands from unrelated families showed that 108 (62%) children had missense variants in gene COL4A5 (62% v. 38%, missense v. non-missense variants, respectively, p=0.028), 24 (13.8%) had mutations leading to impaired RNA splicing, 17 (9.8%) had frameshift mutations, 14 (8%) had gene deletions and 10 (5.7%) had nonsense mutations. Missense variants were predominantly localized in the collagen domain compared to the non-collagen domain (n=102, 94.4%, p<0.001), in exons 18 to 41 (n=94; 94.8%) and were represented by glycine substitutions (n=90, 83.3%). Two common variants were identified in the cohort: NM_033380.3(COL4A5):c.1871G>A (p.Gly624Asp) in 28 (26%) and NM_033380.3(COL4A5):c.3319G>A (p.Gly1107Arg) in 4 (3.7%). Conclusion: the structure of COL4A5 genetic variants in the studied cohort was comparable with the current Worldwide data, such as two thirds of the examined had missense variants and ca. one-fifth had genetic variants leading to the protein synthesis absence. Two common missense variants in gene COL4A5 were identified, including the common variant NM_033380.3(COL4A5):c.1871G>A (p.Gly624Asp) that is of frequent occurrence in the European population.